EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Many Faces of MLKL, the Executor of Necroptosis

Veronica Martinez-Osorio, Yasmin Abdelwahab, Uris Ros

International Journal of Molecular Sciences · 14.06.2023 · 24 (12) · 10108

DOI: 10.3390/ijms241210108 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.06.2023. Verfasst von Veronica Martinez-Osorio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Genetics and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931…. Hauptthemen laut MEDLINE: Apoptosis, Protein Kinases. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DFG, German Research Foundation projects GA 1641/5-1, SFB1403, Special Issue Getting Molecules across Cellular Membranes: Transporters, Channels and Pores.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Necroptosis is a recently discovered form of regulated cell death characterized by the disruption of plasma membrane integrity and the release of intracellular content. Mixed lineage kinase domain-like (MLKL) protein is the main player of this cell death pathway as it mediates the final step of plasma membrane permeabilization. Despite the significant progress in our knowledge of the necroptotic pathway and MLKL biology, the precise mechanism of how MLKL functions remain unclear. To understand in what way MLKL executes necroptosis, it is crucial to decipher how the molecular machinery of regulated cell death is activated in response to different stimuli or stressors. It is also indispensable to unveiling the structural elements of MLKL and the cellular players that are required for its regulation. In this review, we discuss the key steps that lead to MLKL activation, possible models that explain how it becomes the death executor in necroptosis, and its emerging alternative functions. We also summarize the current knowledge about the role of MLKL in human disease and provide an overview of existing strategies aimed at developing new inhibitors that target MLKL for necroptosis intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisProtein KinasesHumansNecroptosisCell DeathCell MembraneReceptor-Interacting Protein Serine-Threonine Kinases

Stichwörter der Autor:innen

MLKLhuman diseasesmembrane permeabilizationnecroptosisregulated cell death

Substanzen

Protein KinasesReceptor-Interacting Protein Serine-Threonine KinasesMLKL protein, human

Autor:innen und Institutionen

  • Institute for Genetics and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.

Förderung

  • DFG, German Research Foundation projects GA 1641/5-1
  • SFB1403
  • Special Issue Getting Molecules across Cellular Membranes: Transporters, Channels and Pores

Zitieren

APA

Martinez-Osorio, V., Abdelwahab, Y., & Ros, U. (2023). The Many Faces of MLKL, the Executor of Necroptosis. International Journal of Molecular Sciences, 24(12), 10108. https://doi.org/10.3390/ijms241210108

Vancouver

Martinez-Osorio V, Abdelwahab Y, Ros U. The Many Faces of MLKL, the Executor of Necroptosis. International Journal of Molecular Sciences. 2023;24(12):10108. doi:10.3390/ijms241210108

BibTeX
@article{MartinezOsorio2023,
  author = {Martinez-Osorio, Veronica and Abdelwahab, Yasmin and Ros, Uris},
  title = {The Many Faces of MLKL, the Executor of Necroptosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {12},
  pages = {10108},
  doi = {10.3390/ijms241210108}
}
Kostenlos starten →